U.S. To List Out 10 Prescription Drugs To Negotiate Prices
A senior Biden White House official said on January 11 that the U.S. administration will provide a list of the ten prescription pharmaceuticals for...
2023 Will See Inflation A Cause of Worry For Global Pharma
As the high inflation threat is on the subsiding verge, the second-round effects may not go away quickly. Pharma may have to go through...
Addressing The Antibiotic Shortage Challenge Across Europe
According to Stella Kyriakides, the EU Health Commissioner, the thought about changes to EU pharmaceutical law shall have robust obligations for medicine supply and...
Detection of High-Risk Patients By Aortic Stability Testing
According to a recent study conducted in collaboration by the University of Eastern Finland and Kuopio University Hospital, patients with ascending aortic dilatation are...
The FDA Has Finalized Its Prescription Drug REMS Guidelines
The FDA's Final Guidance on REMS programmes for prescription medications, has just been published. The document is officially titled Format and Content of a...
Drug Inspection Pact Between Switzerland And United States
The US and Switzerland have agreed to a Mutual Recognition Agreement (MRA) on pharmaceutical Good Manufacturing Practices (GMP).
The US Food and Drug Administration (FDA)...
Considerable Rise In Healthcare Deals Expected In 2023
Pharma companies with plenty of cash were on one side of a $200 billion patent cliff. On the other hand, there were a lot...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...